ArticleCureus2026
Adaptive Palliative Stereotactic Body Radiotherapy for a Large Cervical Lymph Node Metastasis in a Near-Centenarian Patient: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Palliative radiotherapy for very-elderly patients requires rapid symptom relief, short treatment times, fewer hospital visits, and minimal side effects. We report a 99-year-old woman referred to our department by her home-care physician due to severe pain from a rapidly growing, large cervical lymph node metastasis. The initial plan was stereotactic body radiotherapy (SBRT) with a prescribed dose of 24 Gy in three fractions over seven days. Her pain decreased rapidly after the first fraction. Before the third fraction, pre-treatment cone-beam computed tomography for image-guided radiotherapy showed significant tumor shrinkage, with complete resolution of local pain. To minimize the risk of toxicities, we made an adaptive decision to cancel the third fraction. Ultimately, the treatment was completed with a prescribed dose of 16 Gy in two fractions over four days, without any adverse events. The patient passed away peacefully due to old age 56 days after initiating SBRT, maintaining complete pain control until death. Palliative SBRT incorporating adaptive radiotherapy based on intra-treatment imaging and clinical presentation is an effective and safe option for extremely elderly patients. It is important to raise awareness of this low-risk, high-precision treatment in community and palliative care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.